Hye Seung Lee
Overview
Explore the profile of Hye Seung Lee including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
358
Citations
6664
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kim J, Hong H, Park S, Choi J, Suh Y, Kong S, et al.
Eur J Surg Oncol
. 2025 Feb;
:109590.
PMID: 39894713
Background: Lymph node metastasis (LNM) prediction for each LN station is required for tailored surgery for patient safety or improving quality of life in gastric cancer. This retrospective review was...
2.
Lee H
J Gastric Cancer
. 2025 Jan;
25(1):192-209.
PMID: 39822175
Gastric cancer (GC) is a highly heterogeneous disease that varies in both histological presentation and genetic characteristics. Recent advances in the treatment of metastatic and unresectable GC have made several...
3.
Kim J, Na H, Lee S, Kim J, Suh K, Kim S, et al.
Sci Rep
. 2025 Jan;
15(1):2171.
PMID: 39820489
Next-generation sequencing (NGS) cancer profiling has gained traction in routine clinical practice in South Korea. Here, we evaluated the use of NGS testing and genomically-matched therapies for patients with advanced...
4.
Jin H, Jin L, Yoo S, Cho N, Bae J, Kim J, et al.
Histol Histopathol
. 2025 Jan;
18864.
PMID: 39775750
Tumor-infiltrating lymphocyte (TIL) density is both a prognostic and a predictive factor in colorectal cancer (CRC). Whether the heterogeneity of TIL density across the tumor plays an important role in...
5.
Oh S, Kim J, Shin C, Lee H, Lee H, Park K
J Transl Med
. 2025 Jan;
23(1):20.
PMID: 39762979
Background: This study investigated the oral microbiome signatures associated with upper gastrointestinal (GI) and pancreaticobiliary cancers. Methods: Saliva samples from cancer patients and age- and sex-matched healthy controls were analyzed...
6.
Jang D, Hwa C, Kim S, Oh J, Shin S, Lee S, et al.
Adv Sci (Weinh)
. 2024 Nov;
12(3):e2410806.
PMID: 39587835
Immunotherapy holds potential as a treatment for gastric cancer (GC), though immune checkpoint inhibitor (ICI) resistance remains an obstacle. One resistance mechanism involves defects in interferon-γ (IFN-γ) signaling, in which...
7.
Perez-Vilar S, Mosholder A, Smith E, Lee H, Lo A, Stone M, et al.
J Gen Intern Med
. 2024 Nov;
40(3):587-594.
PMID: 39586948
Importance: Acute respiratory failure (ARF) associated with antipsychotic use has been documented through case reports and population-based studies. Objective: To assess whether the recent use of antipsychotics is associated with...
8.
Park J, Nam S, Kwak Y, Oh H, Kong S, Park D, et al.
Sci Rep
. 2024 Nov;
14(1):28810.
PMID: 39567670
Microsatellite instability-high (MSI-H) gastric cancer (GC) exhibits high tumor-infiltrating lymphocyte (TIL) density. Despite the recognized significance of the immune microenvironment in MSI-H GC, our understanding of TIL remains limited. This...
9.
Kim H, Kim Y, Lee H
J Gastric Cancer
. 2024 Oct;
24(4):391-405.
PMID: 39375055
Purpose: Trop family proteins, including epithelial cell adhesion molecule (EpCAM) and Trop-2, have garnered attention as potential therapeutic and diagnostic targets for various malignancies. This study aimed to elucidate the...
10.
Kwak Y, Kim T, Nam S, Hwang H, Han D, Oh H, et al.
Oncologist
. 2024 Sep;
30(2).
PMID: 39306800
Background: Claudin 18.2 (CLDN18.2) is a promising target for targeted therapies in gastric cancer (GC). This study investigated the prevalence of CLDN18.2 expression in patients with stages II-IV GC or...